Effects of prescription drug insurance on hospitalization and mortality: evidence from medicare part D
Contenido multimedia no disponible por derechos de autor o por acceso restringido. Contacte con la institución para más información.
| Tag | 1 | 2 | Valor |
|---|---|---|---|
| LDR | 00000cab a2200000 4500 | ||
| 001 | MAP20190027519 | ||
| 003 | MAP | ||
| 005 | 20190925161920.0 | ||
| 008 | 190925e20190902usa|||p |0|||b|eng d | ||
| 040 | $aMAP$bspa$dMAP | ||
| 084 | $a344.1 | ||
| 100 | 1 | $0MAPA20190013055$aKaestner, Robert | |
| 245 | 0 | 0 | $aEffects of prescription drug insurance on hospitalization and mortality: evidence from medicare part D$cRobert Kaestner, Cuping Schiman, G. Caleb Alexander |
| 520 | $aWe used Medicare administrative data (20022009) and an instrumental variables design that exploits the natural experiment created by the implementation of Medicare Part D to estimate the effect of prescription drug coverage insurance on the use and costs of inpatient services. We find that gaining prescription drug insurance through Part D caused approximately a 4 percent decrease in hospital admission rate, a 25 percent decrease in Medicare inpatient payments per person, and a 1015 percent decrease in inpatient charges. Among specific types of admissions, gaining insurance was associated with significant decreases in admissions for CHF and COPD. | ||
| 650 | 4 | $0MAPA20080626310$aSeguro de asistencia sanitaria | |
| 650 | 4 | $0MAPA20080563288$aMedicamentos | |
| 650 | 4 | $0MAPA20080554750$aHospitales | |
| 650 | 4 | $0MAPA20080555306$aMortalidad | |
| 700 | 1 | $0MAPA20190013062$aSchiman, Cuping | |
| 700 | 1 | $0MAPA20190013079$aAlexander, G. Caleb | |
| 773 | 0 | $wMAP20077000727$tThe Journal of risk and insurance$dNueva York : The American Risk and Insurance Association, 1964-$x0022-4367$g02/09/2019 Volumen 86 Número 3 - septiembre 2019 , p. 595-628 |